Rondo Therapeutics
PrivateLast Round
Series A
Mar 2, 2022
Total Funding Raised
$67M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Rondo Therapeutics is a biotechnology company that develops bispecific therapeutic antibodies aimed at modulating immune system activation to combat cancer, particularly in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rondo Therapeutics Comparables
Compare Rondo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Marengo Therapeutics | 82% | |
| Amgen | 75% | |
| Aktis Oncology | 73% |
Rondo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 2, 2022 |
Key People
Founding team and executive leadership
Rondo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A |
| Novo Holdings | Series A |
| Canaan Partners | Series A |
| Red Tree Venture Capital | Series A |
| Johnson & Johnson Innovation – JJDC | Series A |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 62% MoM, reaching 2.8K.
- Jan 1, 2025
Advanced first oncology asset into clinical trials in 2025.
Rondo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rondo Therapeutics's valuation, stock price, and market status.
Is Rondo Therapeutics a public or private company?
Rondo Therapeutics is a private company.
What is the current stock price of Rondo Therapeutics?
Rondo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Rondo Therapeutics worth (valuation)?
Valuation information for Rondo Therapeutics is not publicly available.
Can I buy Rondo Therapeutics stock?
Rondo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rondo Therapeutics's last funding round?
Rondo Therapeutics's most recent funding round was Series A on March 2, 2022.
Who are the main investors in Rondo Therapeutics?
Key investors in Rondo Therapeutics include Canaan Partners, Red Tree Venture Capital.
Will Rondo Therapeutics IPO soon?
No public IPO plans have been announced for Rondo Therapeutics.
How can I track Rondo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rondo Therapeutics's secondary market activity and sign up for updates.